- Lobbying
- Lobbying by Black Beret Life Sciences, LLC (formerly reporting as Bosarge Life Sciences)
Lobbying Relationship
Bills mentioned
S.2689: REGROW Act
Sponsor: Mark Steven Kirk (R-Ill.)
Lobbyists
Lobbyists named here were listed on a filing related to this lobbying engagement. They may not be working on it now. Occasionally, a single lobbyist whose name is spelled two different ways on filings may be represented twice here.
Lobbyist | Covered positions? |
---|---|
Martina Bradford | Senior Advisor to Sen. Harry Reid (06-10) Deputy Sergeant at Arms, US Senate (10-13) |
Carolyn Mayle | Staff Assistant, Rep. Dan Burton (93-95) Professional Staff, Gov't Reform and Oversight Comm. (96-98) |
Nicole Venable | Leg. Asst. to Senator Charles S. Robb (93-96) USTR Congressional Affairs Specialist (96-98) Sr. Policy Adv. Rep.William Jefferson (98-02) CoS to Rep. William Jefferson (04-05) |
Peter Lawson | Senior Counsel, Rep Jim Moran (02-04); Legislative Asst, Rep Jim Moran (98-00) |
Hayden Rogers | Chief of Staff, Rep. Heath Shuler ('07-'12); Chief of Staff, Sen. Joe Manchin ('13-'15) Chief of Staff, Rep. Heath Shuler ('07-'12); Chief of Staff, Sen. Joe Manchin ('13-'15) |
David Bockorny | n/a |
Disclosures Filed
Once a lobbying engagement begins, the lobbyist or firm is required to file updates four times a year. Those updates sometimes change which lobbyists are involved or add new issues being discussed. When lobbyists stop working for a client, the firm is also supposed to file a report disclosing the end of the relationship.
Termination
Q1 Report
Lobbying Issues
Agencies Lobbied
U.S. House of Representatives
Type of Issue
Science
Q4 Report
Lobbying Issues
Agencies Lobbied
U.S. House of Representatives
Type of Issue
Science
Q3 Report
Lobbying Issues
Agencies Lobbied
U.S. House of Representatives
Type of Issue
Science
Amendment
Lobbying Issues
Agencies Lobbied
U.S. House of Representatives
Type of Issue
Science
Q2 Report
Lobbying Issues
Agencies Lobbied
U.S. House of Representatives
Type of Issue
Science
Amendment
Lobbying Issues
Agencies Lobbied
U.S. House of Representatives
Type of Issue
Science
Q1 Report
Lobbying Issues
Agencies Lobbied
U.S. House of Representatives
Type of Issue
Science
Amendment
Lobbying Issues
Agencies Lobbied
U.S. House of Representatives
Type of Issue
Science
Q4 Report
Lobbying Issues
Agencies Lobbied
U.S. House of Representatives
Type of Issue
Science
Q3 Report
Lobbying Issues
Agencies Lobbied
U.S. House of Representatives
Type of Issue
Science
Q2 Report
Lobbying Issues
Agencies Lobbied
U.S. House of Representatives
Type of Issue
Science
Q1 Report
Lobbying Issues
Agencies Lobbied
U.S. House of Representatives
Type of Issue
Science
Registration
Issue(s) they said they’d lobby about: Issues Related to the Introduction of New Medical Therapies.
Source: Clerk of the U.S. House of Representatives and Secretary of the Senate